col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


90 Results       Page 1

 [1] 
Clinical and Experimental Rheumatology: Pathogenesis of rheumatoid arthritis one year in review 2022
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―08 Cancer-associated myositis before and after the COVID-19 pandemic onset: a comment Hinpetch Daungsupawong, Viroj Wiwanitkit
2 [GO] 2024―Mar―14 Cancer-associated myositis before and after the COVID-19 pandemic onset: a changing trend Filipa M. Costa, Raquel Campanilho-Marques, Eduardo Dourado, Matilde Bandeira, Bianca Correia, Ana Teresa Melo, et al. (+3)
3 [GO] 2024―Feb―19 Dynamics of SARS-CoV-2 IgG antibodies and neutralising antibodies in rheumatic and musculoskeletal diseases patients with COVID-19 Qi Wang, Yunjuan Wu, Lingyun Wu, Chengyin Lu, Yao Ke, Yanyan Wang, et al. (+3)
4 [GO] 2023―Dec―27 Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic Claudia Carmassi, Chiara Tani, Valentina Lorenzoni, Ilaria Palla, Giovanni Fulvio, Sara Fantasia, et al. (+7)
5 [GO] 2023―Dec―26 COVID-19 prevalence and all-cause mortality among musculoskeletal inpatients in Nairobi, Kenya in comparison to non-musculoskeletal patients Benwillies Onchong'a, Tuulikki Sokka-Isler, Pekka Mäntyselkä, Ari Voutilainen
6 [GO] 2023―Oct―25 Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients Christian Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen, Jens Magnus Bernth Jensen, Rafael Bayarri-Olmos, Peter Garred, et al. (+15)
7 [GO] 2023―Sep―22 Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort Alice Bartoletti, Chiara Fornara, Paolo Delvino, Giulia Franchi, Alessandro Ferrari, Fausto Baldanti, et al. (+2)
8 [GO] 2023―Jul―26 The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients. Gemma Lepri, Martina Orlandi, Silvia Bellando-Randone, Marco Matucci-Cerinic, Serena Guiducci
9 [GO] 2023―Jun―28 Adverse effects of the COVID-19 pandemic on fibromyalgia patients in Germany: a longitudinal investigation including pre-pandemic data of pain and health-related outcomes Benjamin Mosch, Verena Hagena, Stephan Herpertz, Martin Diers
10 [GO] 2023―Jun―05 Chronic chilblain-like lesions occurring during the Covid pandemic: case series Joseph Nathan, Anshul Rastogi, Patrick D.W. Kiely
11 [GO] 2023―Apr―20 Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study Richard S. Henry, Linda Kwakkenbos, Marie-Eve Carrier, Scott Patten, Susan J. Bartlett, Luc Mouthon, et al. (+3)
12 [GO] 2023―Mar―10 The impact of the COVID-19 pandemic on patients with Behçet's syndrome within the framework of Maslow's hierarchy of needs: implications for patient empowerment in national or global emergencies Farida Fortune, John Mather, Nur Şişman-Kitapci, Bindi Gokani, Amal Senusi, Gonca Mumcu
13 [GO] 2023―Feb―24 Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease Caoilfhionn M. Connolly, Andrew H. Karaba, Teresa Po-Yu Chiang, Mayan Teles, Jake D. Kim, Trevor Scott Johnson, et al. (+5)
14 [GO] 2023―Feb―23 Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience Fadi Kharouf, Ariel Kenig, Emilie Bohbot, Limor Rubin, Hagit Peleg, Oded Shamriz
15 [GO] 2023―Feb―16 Idiopathic inflammatory myopathies and COVID-19: an intriguing liaison? Lorenzo Cavagna, Francesco Ferro, Giovanni Zanframundo, Gaetano La Rocca, Ilaria Puxeddu
16 [GO] 2023―Feb―13 Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination Maurizio Cutolo, Vanessa Smith, Sabrina Paolino
17 [GO] 2023―Feb―13 COVID-19: the new challenge for rheumatologists. First update Francesco Ferro, Elena Elefante, Ilaria Puxeddu, Chiara Baldini, Elena Bartoloni, Claudia Baratè, et al. (+4)
18 [GO] 2023―Feb―10 Blood transcriptome and machine learning identified the crosstalk between COVID-19 and fibromyalgia: a preliminary study Zhao Zhang, Zhijie Zhu, Dong Liu, Zhenz Mi, Huiren Tao, Hongbin Fan
19 [GO] 2023―Jan―09 Reply to comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver Ioana Andreica, Xenofon Baraliakos, Juergen Braun
20 [GO] 2023―Jan―09 Comment on: Changes in immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver Weijie Wang, Jian Wang
21 [GO] 2022―Nov―28 Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome Nevsun Inanc, Belchin Kostov, Roberta Priori, Alejandra Flores-Chavez, Francesco Carubbi, Antónia Szántó, et al. (+20)
22 [GO] 2022―Nov―15 High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe Maša Bizjak, Nina Emeršič, Mojca Zajc Avramovič, Fabio Barbone, Federico Ronchese, Sara Della Paolera, et al. (+18)
23 [GO] 2022―Oct―13 Factors influencing the course of COVID-19 in the inflammatory rheumatic diseases Selda Celik, Muhammet Emin Kutu, Cengiz Bal, Burcak Karadeniz, Pamir Atagunduz, Mehmet Soy
24 [GO] 2022―Sep―22 Incidence of autoantibodies related to systemic autoimmunity in patients with severe COVID-19 admitted to the intensive care unit Kleopatra Bitzogli, Edison Jahaj, Athanasios-Dimitrios Bakasis, Efstathia K. Kapsogeorgou, Andreas V. Goules, Ioanna Stergiou, et al. (+8)
25 [GO] 2022―Sep―22 Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs Ludovico De Stefano, Silvia Balduzzi, Laura Bogliolo, Bernardo D'Onofrio, Michele di Lernia, Eleonora Mauric, et al. (+7)
26 [GO] 2022―Sep―05 Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction Rula Daood, Kochava Toledano, Doron Markovits, Yonit Tavor, Samy Giryes, Katya Dolnikov, et al. (+3)
27 [GO] 2022―Sep―05 Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren's syndrome patients Tobit D. Steinmetz, Liseth de Wolff, Janneke H. Terpstra, Annie Visser, Hendrika Bootsma, Frans G.M. Kroese, Gwenny M. Verstappen
28 [GO] 2022―Aug―05 New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort Michela Gasparotto, Sara Bindoli, Roberto Padoan, Giacomo Cozzi, Roberto Depascale, Elisabetta Zanatta, et al. (+8)
29 [GO] 2022―Aug―02 Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres Dominik Vogler, Piero Ruscitti, Luca Navarini, Roberto Giacomelli, Annamaria Iagnocco, Paula Hoff, et al. (+2)
30 [GO] 2022―Jul―27 Comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection Alexandros A. Drosos, Eleftherios Pelechas, Aliki I. Venetsanopoulou, Paraskevi V. Voulgari
31 [GO] 2022―Jul―26 Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE Emilie Stavnsbjerg Larsen, Anna Christine Nilsson, Sören Möller, Anne Boertmann Voss, Isik Somuncu Johansen
32 [GO] 2022―Jul―21 The effect of COVID-19 pandemic on idiopathic inflammatory myositis patients: a single centre experience Tibor Béldi, Anett Vincze, Balázs Miltényi-Szabó, Zsófia Varga, Katalin Szabó, Zoltán Griger, Melinda Nagy-Vincze
33 [GO] 2022―Jul―21 COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis Caterina Vacchi, Sofia Testoni, Marcella Visentini, Roberta Zani, Gianfranco Lauletta, Laura Gragnani, et al. (+15)
34 [GO] 2022―Jul―06 Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection Eli Ben-Chetrit, Eldad Ben-Chetrit
35 [GO] 2022―Jul―06 Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia Giovanni Guaraldi, Federico Banchelli, Jovana Milic, Giovanni Dolci, Marco Massari, Romina Corsini, et al. (+7)
36 [GO] 2022―Jul―06 High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019 Giovanni Dolci, Giulia Cassone, Francesco Venturelli, Giulia Besutti, Matteo Revelli, Romina Corsini, et al. (+11)
37 [GO] 2022―Jul―06 Virtual teaching for medical students during SARS-CoV-2 pandemic Alexander Pfeil, Marcus Franz, Tobias Hoffmann, Philipp Klemm, Peter Oelzner, Ulf Müller-Ladner, et al. (+6)
38 [GO] 2022―Jul―04 Counselling patients for return to work on immunosuppression: practices of Canadian specialists during the COVID-19 pandemic Karim Ladak, Kevin Winthrop, John K. Marshall, Joel Gelfand, Janet Pope
39 [GO] 2022―Jul―01 Clinical course of COVID-19 infections in patients with Behçet's disease in the Netherlands A.A. Sophie den Otter, Tim B. van der Houwen, P. Martin van Hagen, Jan A.M. van Laar
40 [GO] 2022―Jun―22 Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? Rebecca Hasseli, Alexander Pfeil, Bimba F. Hoyer, Andreas Krause, Hanns-Martin Lorenz, Jutta G. Richter, et al. (+5)
41 [GO] 2022―Jun―22 Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long Maria Vincenza Mastrolia, Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, Gabriele Simonini
42 [GO] 2022―Jun―22 COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease Yasushi Kondo, Yuko Kaneko, Hiroshi Takei, Hiroya Tamai, Hiroki Kabata, Tomohiro Suhara, et al. (+7)
43 [GO] 2022―Jun―22 Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection Alberto Batticciotto, Daniela Marotto, Valeria Giorgi, Patrizia Balzarini, Ennio Giulio Favalli, Silvia Balduzzi, et al. (+18)
44 [GO] 2022―Jun―22 SARS-CoV-2 infection in patients with systemic autoimmune diseases Pilar Brito-Zerón, Antoni Sisó-Almirall, Alejandra Flores-Chavez, Soledad Retamozo, Manuel Ramos-Casals
45 [GO] 2022―Jun―21 Epidemiology and clinical characteristics of COVID-19 in rheumatic diseases at a tertiary care hospital in Wuhan, China Min Chen, Yanhong Wei, Qianhui Zhang, Qianqian Wan, Xiaoqi Chen
46 [GO] 2022―Jun―14 Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose Camille Le Moine, Muhammad S. Soyfoo, Leila Mekkaoui, Hafid Dahma, Laure Tant
47 [GO] 2022―Jun―09 COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Piercarlo Sarzi-Puttini, Valeria Giorgi, Silvia Sirotti, Daniela Marotto, Sandro Ardizzone, Giuliano Rizzardini, et al. (+2)
48 [GO] 2022―Jun―09 Therapies used in rheumatology with relevance to coronavirus disease 2019 Gilberto Pires da Rosa, Ester Ferreira
49 [GO] 2022―Jun―09 COVID-19: the new challenge for rheumatologists Francesco Ferro, Elena Elefante, Chiara Baldini, Elena Bartoloni, Ilaria Puxeddu, Rosaria Talarico, et al. (+2)
50 [GO] 2022―May―05 Optimising ANCA-associated vasculitis management and infectious risks during the COVID-19 pandemic Loïc Guillevin, Benjamin Terrier
51 [GO] 2022―May―02 Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study Greta Pellegrino, Silvia Mancuso, Tania Colasanti, Stefania Mieli, Chiara Gioia, Raffaella Izzo, et al. (+5)
52 [GO] 2022―Apr―13 COVID-19: the new challenge for rheumatologists. One year later Ilaria Puxeddu, Francesco Ferro, Elena Bartoloni, Elena Elefante, Chiara Baldini, Carlo Alberto Scirè, et al. (+4)
53 [GO] 2022―Apr―13 Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives Maurizio Benucci, Maria Infantino, Daniela Marotto, Sandro Ardizzone, Mariangela Manfredi, Piercarlo Sarzi-Puttini
54 [GO] 2022―Apr―12 COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave Marco Tasso, Erika Mostacciuolo, Valentina Ugoccioni, Antonio Del Puente, Rosario Peluso, Raffaele Scarpa, et al. (+2)
55 [GO] 2022―Apr―12 Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, José Correa-Fernández, Sergio Sanz-Gómez, Victoria Navarro-Compán
56 [GO] 2022―Apr―12 Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine Víctor Moreno-Torres, Ángela Gutiérrez, María Valdenebro, Alfonso Ortega, María-Jesús Cítores, Esther Montero
57 [GO] 2022―Apr―12 Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis Paolo Delvino, Emanuele Bozzalla-Cassione, Alessandro Biglia, Verdiana Serena Quadrelli, Alice Bartoletti, Carlomaurizio Montecucco, Sara Monti
58 [GO] 2022―Apr―12 Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosis Eugenia Bertoldo, Riccardo Bixio, Davide Bertelle, Denise Rotta, Ombretta Viapiana, Maurizio Rossini
59 [GO] 2022―Apr―12 Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosis. Reply to Bertoldo et al. Jacopo Ciaffi, Francesco Ursini
60 [GO] 2022―Apr―11 Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver Ioana Andreica, Robert Jast, Guenther A. Rezniczek, David Kiefer, Bjoern Buehring, Uta Kiltz, et al. (+2)
61 [GO] 2022―Apr―07 Incidence and risk factors of COVID-19 in patients with vasculitis in the first year of the pandemic: a Danish nationwide cohort study Salome Kristensen, René Cordtz, Kirsten Duch, Jesper Lindhardsen, Christian Torp-Pedersen, Lene Dreyer
62 [GO] 2022―Apr―07 Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort Marcelo M. Pinheiro, Gecilmara S. Pileggi, Adriana M. Kakehasi, Ana Paula M. Gomides Reis, Edgard Torres Reis-Neto, Mirhelen M. Abreu, et al. (+33)
63 [GO] 2022―Apr―07 The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome Fausto Salaffi, Valeria Giorgi, Silvia Sirotti, Sara Bongiovanni, Sonia Farah, Laura Bazzichi, et al. (+7)
64 [GO] 2022―Apr―07 Physical and mental impact of COVID-19 outbreak on fibromyalgia patients Valerie Aloush, Avital Gurfinkel, Noam Shachar, Jacob N. Ablin, Odelia Elkana
65 [GO] 2022―Apr―07 COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis Yuta Norimatsu, Ayumi Yoshizaki, Takemichi Fukasawa, Satoshi Ebata, Koji Oba, Shinichi Sato
66 [GO] 2022―Apr―07 Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study Javier Rivera, Isabel Castrejón, Laura Vallejo-Slocker, Martin Offenbächer, Juan Molina-Collada, Laura Trives, et al. (+7)
67 [GO] 2022―Apr―07 Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis Cristina Iannuccelli, Bruno Lucchino, Chiara Gioia, Giulio Dolcini, Martina Favretti, Daniele Franculli, Manuela Di Franco
68 [GO] 2022―Apr―07 COVID-19 vaccine hesitancy in systemic sclerosis Jacopo Ciaffi, Dilia Giuggioli, Anna Mari, Martina D'Onghia, Amelia Spinella, Veronica Brusi, et al. (+8)
69 [GO] 2022―Apr―07 Systemic sclerosis and COVID-19: what's new in the literature Barbara Russo, Jennifer Ben Shimol, Marco Matucci-Cerinic, Cosimo Bruni
70 [GO] 2022―Apr―06 Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine Shintaro Yamamoto, Keisuke Nishimura, Kohei Yo, Daisuke Waki, Hiroyuki Murabe, Toshihiko Yokota
71 [GO] 2022―Apr―06 Comment on: Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' by Giollo et al. Duriad Reffat, Magdalena Dziedzic, Ann O' Riordan, Fahd Adeeb
72 [GO] 2022―Apr―06 Prevalence and characteristics of systemic autoimmune disease-related autoantibodies in convalescent patients after SARS-CoV-2 infection Antonio Rosales-Castillo, José Mario Sabio
73 [GO] 2022―Apr―06 The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience Despina N. Maritsi, Panaguotis Krepis, George Vartzelis, Aggeliki Syggelou, Maria Tsolia
74 [GO] 2022―Apr―06 Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome Irene Mattioli, Alessandra Bettiol, Elena Silvestri, Maria Letizia Urban, Adalgisa Palermo, Filippo Fagni, et al. (+4)
75 [GO] 2022―Apr―06 SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children Ji Hee Kwak, Jong-Woon Choi, Soo-Young Lee
76 [GO] 2022―Apr―06 Systemic lupus erythematosus flare following SARS-CoV2 infection: the implication of IFNα and anti-IFNα autoantibodies Arthur Mageau, Pascale Nicaise Roland, Tiphaine Goulenok, Carine Farkh, Nicolas Charles, Karim Sacre
77 [GO] 2022―Apr―05 Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus Silvia Mancuso, Francesca Romana Spinelli, Luciano Agati, Maria Rosa Ciardi, Cristina Garufi, Francesco Natalucci, et al. (+6)
78 [GO] 2022―Apr―05 Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis Anne-Claire Desbois, Cindy Marques, Leila Lefèvre, Serge Barmo, Camille Lorenzo, Mathilde Leclercq, et al. (+7)
79 [GO] 2022―Apr―05 Severity of COVID-19 infection in primary Sjögren's syndrome and the emerging evidence of COVID-19-induced xerostomia Farzana Chowdhury, Sofia Grigoriadou, Michele Bombardieri
80 [GO] 2022―Apr―05 Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology Anna Zanetti, Greta Carrara, Gianpiero Landolfi, Davide Rozza, Cecilia Beatrice Chighizola, Alessia Alunno, et al. (+14)
81 [GO] 2022―Apr―05 High incidence of giant cell arteritis during the COVID-19 pandemic: no causal relationship but possible involvement of stress Simon Parreau, Eric Liozon, Kim-Heang Ly, Anne-Laure Fauchais, Sébastien Hantz
82 [GO] 2022―Apr―05 COVID-19 vaccination unveiling subclinical Sjögren's syndrome Manuel Ramos-Casals, Maite Sainz-de-la-Maza, Africa Muxí
83 [GO] 2022―Apr―05 Henoch-Schönlein purpura with renal and gastrointestinal involvement in course of COVID-19: a case report Laura Barbetta, Giovanni Filocamo, Emanuela Passoni, Francesca Boggio, Christian Folli, Valter Monzani
84 [GO] 2022―Apr―05 Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection Jennifer R. Hannah, Saadia Sasha Ali, Deepak Nagra, Maryam A. Adas, April D. Buazon, James B. Galloway, Patrick A. Gordon
85 [GO] 2022―Apr―05 Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases Tali Eviatar, Victoria Furer, Ari Polachek, David Levartovsky, Ofir Elalouf, Michael Zisapel, et al. (+6)
86 [GO] 2022―Apr―05 Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection Pilar Brito-Zerón, Nihan Acar-Denizli, Vasco C. Romão, Berkan Armagan, Raphaèle Seror, Francesco Carubbi, et al. (+18)
87 [GO] 2022―Apr―05 Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis Salvatore Scarpato, Marco Sebastiani, Luca Quartuccio, Piero Marson, Paolo Fraticelli, Laura Castelnovo, et al. (+9)
88 [GO] 2022―Mar―25 The decrease of Kawasaki syndrome during the second COVID-19 wave: a potential, unexpected effect of social distancing Maria Vincenza Mastrolia, Rino Agostiniani, Chiara Azzari, Roberto Bernardini, Ugo Bottone, Giovanni Battista Calabri, et al. (+19)
89 [GO] 2022―Mar―25 Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies Gollapalle L. Viswanatha, CH.K.V.L.S.N. Anjana Male, Hanumanthappa Shylaja
90 [GO] 2022―Mar―25 SARS-CoV-2 in the knee joint: a cadaver study Miriam Grassi, Valeria Giorgi, Manuela Nebuloni, Pietro Zerbi, Maria Rita Gismondo, Fausto Salaffi, et al. (+3)
 [1] 

90 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec